Regeneron Hires Firm to Market Former Avon R&D Facility in Suffern for Sale or Lease
Regeneron Pharmaceuticals abandoned plans last November to spend $139 million to renovate the former Avon Products facility it had acquired in December 2023 for $38,875,000 from Avon Capital Corp.
From left, Chris Pagli, Christina Stevens, Carol McCann, Rey Hollingsworth Falu, Carol Christiansen, Anthony Domathoti, HGAR President, Gail Fattizzi, Joseph Houlihan, Barry Kramer, Katheryn DeClerck and Gary Leogrande
Carol Christiansen, Broker/Owner/Manager Committee Co-Chair
Lou Budetti (center) participates in one of the mini-sessions at the event.
Chris Pagli (center) leads one of the breakout sessions at the event.
From left, Jeanne Shields, Beatriz Alvarez and Dorothy Botsoe
From left, Cynthia Lippolis, Gail Fattizzi, and Aaron Velez
From left, Barry Kramer and John Crittenden
Gary Leogrande (front left) leads one of the breakout discussion topics.
Rey Hollingsworth Falu, Broker/Owner/Manager Committee Co-Chair
Thank you to event sponsors: Allan Block Insurance, HomeTeam Inspection Services, National Tenant Network, Real Grader, Trustco Bank and Wells Fargo Home Mortgage.